GTHP developed a biophotonic cervical cancer scan that will replace 60 million annual PAP smear tests.
It's noninvasive, more accurate and produces instant test results.
A new marketing whiz CEO was recently hired. He was formerly with GE Diagnostics and Abbott Healthcare.
A $3M order was received from Turkey and dozens of distributors were signed up.
Get in on the ground floor.
PROFIT POTENTIAL: $15 per disposable x 60M = $900M PLUS $19,000 per machine PLUS international sales = HUGE PROFITS
Multiple aliases (ID's) talking to himself idiot!
Should I buy GTHP or lose all my money on RSH?
Nice looking stock.
Any stock is superior to RSH accept for maybe GALE and INO.
It's the real deal.
One share of RSH will get you 4 shares of GTHP.
It will be the best trade that you'll ever make in your life.